Science Explorer Back to mapMap

Most cited papers from Essen BioScience (United States)

What are the most cited papers from Essen BioScience (United States)?

The most cited paper from Essen BioScience (United States) is "IonWorks™ HT: A New High-Throughput Electrophysiology Measurement Platform" (Kirk S. Schroeder, Brad Neagle, Derek J. Trezise et al., 2003), with 222 citations. Next come "High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage Clamp" (121) and "A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors" (52).

Showing 32 of 32 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 IonWorks™ HT: A New High-Throughput Electrophysiology Measurement Platform Kirk S. Schroeder, Brad Neagle, Derek J. Trezise et al. · SLAS DISCOVERY Open access 2003 222
2 High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage Clamp László Kiss, Paul B. Bennett, Victor N. Uebele et al. · Assay and Drug Development Technologies Feb 2003 121
3 A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors Mari Carmen Vazquez-Borrego et al. · Clinical Cancer Research 17 Oct 2019 52
4 HTS assays for developing the molecular pharmacology of ion channels Owen B. McManus · Current Opinion in Pharmacology Review 18 Feb 2014 44
5 A Multiplexed Method for Kinetic Measurements of Apoptosis and Proliferation Using Live-Content Imaging Katherine A. Artymovich, Daniel M. Appledorn · Methods in molecular biology Book chapter 18 Sep 2014 36
6 Tissue mechanics drives regeneration of a mucociliated epidermis on the surface of Xenopus embryonic aggregates Hye Young Kim, Timothy R. Jackson, Carsten Stuckenholz et al. · Nature Communications Open access 31 Jan 2020 34
7 Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat Mahesh Thirunavukkarasu, Vaithinathan Selvaraju, Nageswara Rao Dunna et al. · International Journal of Cardiology 17 Apr 2013 29
8 Gelatin methacrylate-alginate hydrogel with tunable viscoelastic properties Yong X. Chen, Brian P. Cain, Pranav Soman · AIMS Materials Science Open access 2017 22
9 Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition Beverly L. Falcón, Belinda O’Clair, Don B. McClure et al. · Journal of Hematology & Oncology Open access 27 Apr 2013 20
10 Pharmacologic Characterization of a Kinetic In Vitro Human Co-Culture Angiogenesis Model Using Clinically Relevant Compounds Ashley Wolfe, Belinda O’Clair, Vincent E. Groppi et al. · SLAS DISCOVERY Open access 9 Sep 2013 19
11 Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats Vaithinathan Selvaraju, Sumanth Channapatna Suresh, Mahesh Thirunavukkarasu et al. · Journal of Cardiovascular Translational Research 9 Mar 2017 13
12 A “successful allele” at Campylobacter jejuni contingency locus Cj0170 regulates motility; “successful alleles” at locus Cj0045 are strongly associated with mouse colonization Katherine A. Artymovich, Joo-Sung Kim, John E. Linz et al. · Food Microbiology Open access 23 Jan 2013 10
13 Kinetic Measurement of Apoptosis and Immune Cell Killing Using Live-Cell Imaging and Analysis Jill E. Granger, Daniel M. Appledorn · Methods in molecular biology Book chapter 14 Dec 2020 9
14 A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for 68Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors Irene Johanna Virgolini, Shadfar Bahri, Andreas Kjær et al. · Journal of Nuclear Medicine Open access 2 Jul 2021 8
15 Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactors Pierre Springuel, Tiffany Hood, Fern Slingsby et al. · Frontiers in Bioengineering and Biotechnology Open access 2 Jun 2025 7
16 Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy Niranjan Awasthi, Margaret A. Schwarz, Changhua Zhang et al. · Molecular Cancer Therapeutics Open access 2 May 2022 6
17 LB01 SIX WEEKS OF SOFOSBUVIR/LEDIPASVIR TREATMENT OF ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: FINAL RESULTS OF THE THE GERMAN HEPNET ACUTE HCV IV STUDY Katja Deterding et al. · United European Gastroenterology Journal Open access270 authors 29 Nov 2016 5
18 An old probe sheds new light on BK channel pore structure Owen B. McManus, Brad S. Rothberg · The Journal of General Physiology Open access 10 Nov 2014 4
19 Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno‐inflammatory diseases Farzaneh Maleki, Elias D. Clark, Christopher R. Banfield et al. · CPT Pharmacometrics & Systems Pharmacology Open access 8 Feb 2024 3
20 A simplified co-culture reveals altered cardiotoxic responses to doxorubicin in hPSC-derived cardiomyocytes in the presence of endothelial cells Marcella Brescia, James Gallant, Andrea Chatrian et al. · Stem Cell Reports Open access 12 Feb 2026 2
21 Genetic Factors Associated with Absolute and Relative Plasma Concentrations of Calcitriol Robin Taylor Wilson, Susan E. Safford, Quinn T. Ostrom et al. · Cancer Epidemiology Biomarkers & Prevention 14 Feb 2023 2
22 Risk assessment for high-grade prostate cancer using a novel cancer-specific biomarker assay derived from autoantibody signatures Xiaoju Wang, Jason M. Hafron, Stephen J. Freedland et al. · Biomedical Research and Clinical Practice Open access 2017 2
23 Evaluating the Impact of Enfortumab Vedotin Dose Modifications on Clinical Efficacy Using Tumor Growth Inhibition Modeling in Patients With Advanced Urothelial Cancer Vaishali L. Chudasama, Gabriela Patilea‐Vrana, Hong Mu et al. · The Journal of Clinical Pharmacology Open access Jul 2026 1
24 A novel read methodology to evaluate the optimal dose of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with GEP-NETs in a phase II clinical trial Colin G. Miller, Irene Johanna Virgolini, Andreas Kjær et al. · Journal of Nuclear Medicine May 2020 1
25 ACCELERATING MULTIPARAMETRIC T-CELL PROFILING USING HIGH-THROUGHPUT SCREENING CYTOMETRY J. Wills, A. H. Gonzalez, N. Bevan et al. · Cytotherapy 30 Apr 2026 0
26 Scalable CAR-T production in a 2-litre perfusion stirred-tank bioreactor with automated harvesting and scale-down model characterisation Pierre Springuel, Pedro Silva Couto, Dale J. Stibbs et al. · Frontiers in Bioengineering and Biotechnology Open access 12 Jan 2026 0
27 A phase II clinical trial to evaluate the optimal activity range and peptide mass dose range of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with GEP-NETs Irene Johanna Virgolini, Shadfar Bahri, Andreas Kjær et al. · Journal of Nuclear Medicine May 2020 0
28 Improved risk assessment using a novel cancer-specific biomarker assay derived from autoantibody signatures for men with non-aggressive prostate cancer who are not receiving treatment Xiaoju Wang, Jason M. Hafron, Heng Yu et al. · Biomedical Research and Reviews Open access 2017 0
29 Ein neuartiger Assay zur Messung chemotaktischer Migration in Echtzeit Lindy O’Clair, Bernhard Ellinger, Milena Kalmer et al. · BIOspektrum Mar 2017 0
30 Rapid Selection of RNA Aptamers that Activate Fluorescence of Small Molecules Grigory S. Filonov · Methods in molecular biology Book chapter 2017 0
31 ITOC2 – 013. In vitro kynurenine modulation by novel dual-acting and selective TDO and IDO inhibitors Alan Wise, Mcguinness E. Barry, Cowley M. Phillip et al. · European Journal of Cancer Mar 2015 0
32 Fluorescent human co-culture angiogenesis assay: analysis of pro-angiogenic growth factors Dyke P. McEwen, Libby Oupicka, Eric W. Endsley et al. · BioTechniques Open access Mar 2010 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.